TBPH News and Press, Theravance Biopharma Inc. From 11/16/23

2023-11-16 20:59:03 ET Summary Baupost Group's 13F portfolio value decreased from $5.61B to $5.21B this quarter. The portfolio is heavily concentrated with Liberty Global, Liberty Media Sirius XM, Veritiv, Alphabet, and Fidelity National Information Services accounting for ~56% of...

Theravance Biopharma to Present New Ampreloxetine Data at the 34th International Symposium on The Autonomic Nervous System PR Newswire DUBLIN , Nov. 16, 2023 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) ...

Theravance Biopharma to Participate in the 6th Annual Evercore ISI HealthCONx Conference PR Newswire DUBLIN , Nov. 15, 2023 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a Fireside Chat at the 6 th Annual Evercore ISI...

Viatris and Theravance Biopharma Announce Positive Top-Line Results from YUPELRI® (revefenacin) Phase III Trial in China for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) PR Newswire Top-line results from Phase III study in China demonstrate the effica...

2023-11-07 23:23:07 ET Theravance Biopharma, Inc. (TBPH) Q3 2023 Earnings Conference Call November 07, 2023, 05.00 PM ET Company Participants Rick Winningham - Chief Executive Officer Rhonda Farnum - Chief Business Officer Rick Graham - Head of Research and Devel...

2023-11-07 16:51:13 ET More on Theravance Biopharma Theravance: Positive Findings Boost Ampreloxetine Development Theravance, Mylan settle patent litigation over COPD drug Yupelri Seeking Alpha’s Quant Rating on Theravance Biopharma For further details...

Theravance Biopharma, Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update PR Newswire Q3 2023 YUPELRI ® (revefenacin) net sales, recognized by Viatris, increased 9% from Q3 2022, reaching an all-time high of $58.3 million 1 ...

Weyco Group Inc. (WEYS) is expected to report for Q1 2024 Gladstone Land Corporation (LAND) is expected to report $0.16 for Q3 2023 PlayAGS Inc. (AGS) is expected to report $0.01 for Q3 2023 Ardmore Shipping Corporation (ASC) is expected to report $0.43 for Q3 2023 Sage Therapeuti...

Theravance Biopharma Inc. (TBPH) is expected to report $-0.21 for Q3 2023

2023-10-30 18:50:40 ET More on Theravance Biopharma, Teva Pharmaceutical, etc. Viatris: Get Paid 5%, Before Growth Materializes Viatris' Survival Guide: Strategic Divestitures And Margins Viatris: Generic Semaglutide Could Become The Poor Man's Option For Weight Loss...